Co-Diagnostics, Inc

This morning, #CODX announced it is the recipient of a grant award from the Bill & Melinda Gates Foundation for its tuberculosis test planned for the company's Co-Dx PCR platform. This is the third grant award from the Gates Foundation this year, following two earlier awards to support the development of the tuberculosis test as well as a test for human papillomavirus (HPV). The new Co-Dx platform technology is expected to play a role in the decentralization of #diagnostics, allowing more patients to benefit from real-time PCR diagnostics, including those in areas of the world where infrastructure has been a barrier to access. #POCT #pcrtesting  #stopTB The Co-Dx PCR platform and its associated products are subject to FDA review and are not available for sale. https://lnkd.in/dYBZQHCT

A new report from the European Centre for Disease Prevention and Control highlights why #CODX PCR-based vector control technology is so important: “Europe is already seeing how climate change is creating more favourable conditions for invasive mosquitos to spread into previously unaffected areas and infect more people with diseases such as dengue...Personal protective measures combined with vector control measures, early detection of cases, timely surveillance, further research and awareness-raising activities are paramount in those areas in Europe most at risk.” As climate change exacerbates challenges, Co-Diagnostics' vector control solutions are even more important, enabling real-time, on-site surveillance of mosquito populations. https://lnkd.in/dY8Y9C5e #MosquitoWeek #PCR #VectorControl

The latest article describing how climate change is "expanding the reach" of insect-borne disease details Las Vegas' exploding mosquito population and calls it a "case study of what's to come." #CODX has developed a vector control PCR platform equipment that makes it possible for onsite, real-time interrogation of mosquito samples, dramatically reducing turnaround times so that abatement districts can act quickly. #mosquitos #mosquitoabatement https://lnkd.in/dNASFJ3H

Another National #MosquitoControlAwarenessWeek is here, and Co-Dx #VectorSmart solutions are supporting front-line mosquito abatement efforts to keep us safe from infectious and vector-borne diseases like #westnile and St. Louis encephalitis in districts across the country. Read more about how we work with mosquito abatement districts for onsite sample analysis that informs vector control: https://lnkd.in/gM4XE-U2 #MosquitoWeek

A reminder that vector-borne diseases aren't limited to tropical or subtropical climates. Don't forget your mosquito repellent this summer: https://lnkd.in/gbRGTjWp #MosquitoControlAwarenessWeek #MosquitoWeek #VectorSmart

Deseret News recently published a story delving into the intersection of AI and healthcare, exploring both its benefits and challenges. As part of the story, Co-Diagnostics was highlighted for the innovative use of machine learning/AI including in test design. Proprietary AI algorithms identify the best possible location in a microorganism's genome to design a Co-Primers test, and the Company also foresees a world where diagnoses can even be data-driven (using information provided by the Co-Dx PCR Pro), powered by AI. This underscores our commitment to leveraging cutting-edge technology for impactful healthcare solutions. Take a look at the full story in Deseret News to learn more about this fascinating intersection of science and innovation! https://lnkd.in/gkDDvrXa #POCT #PCR #AI

Today #CODX employees and distributors concluded a visit to #APRC2024 in Taiwan, discussing how the Co-Dx PCR Pro instrument can play an important role in reducing the burden of #TB around the world. #EndTB #PCR

News coverage of the Co-Dx grand opening event last week for our new manufacturing facility in South Salt Lake. The Co-Dx PCR Pro instrument, currently under review by the FDA, is part of a #POCT PCR platform for detection of infectious diseases, including respiratory diseases and STIs. Thanks ABC4 Utah - Utah's CW30 (KTVX/KUCW) https://lnkd.in/gu-Rfp4B

Earlier today, Co-Diagnostics formally opened a new manufacturing facility producing the Co-Dx PCR diagnostic platform, designed for at-home and point-of-care use. In this clip, #CODX CEO Dwight Egan explains the instrument's future versatility #POCT #PCR https://lnkd.in/g-D-PFYN

This afternoon, Co-Diagnostics will formally open a new manufacturing facility in Salt Lake City that will support the commercialization of the Co-Dx PCR diagnostics instrument for at-home and point-of-care use, and the growing menu of tests being developed for the platform. #POCT